Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

India Equities: Indian Banks, Educomp, HCL Infosystems, Panacea

Aug. 18 (Bloomberg) -- Shares of the following companies had unusual moves in Indian trading. Stock symbols are in parentheses and prices are as of the 3:30 p.m. close in Mumbai.

India’s Bombay Stock Exchange’s Sensitive Index, or Sensex, declined 2.2 percent to 16,469.79. The BSE200 Index fell 2.2 percent to 2,038.45.

Indian Banks: Indian bank stocks dropped on speculation the central bank may raise interest rates for a 12th time since March 2010 to combat inflation, threatening company earnings.

ICICI Bank Ltd. (ICICIBC IN), India’s second-largest bank, lost 5.1 percent to 863.8 rupees. Axis Bank Ltd. (AXSB IN), sank 5.2 percent. State Bank of India Ltd. (SBIN IN), the county’s largest lender, fell 4.2 percent to 2,078.4 rupees.

Educomp Solutions Ltd. (EDSL IN), the computer trainer, tumbled 8.8 percent to 234.8 rupees, its lowest since April 2007, after ET Now television reported the company’s offices were searched by income-tax authorities. Two calls made to the mobile phone of Chairman and Managing Director Shantanu Prakash weren’t answered.

HCL Infosystems Ltd. (HCLI IN) dropped 9.7 percent to 67.05 rupees, the worst loss since February 2009. The Indian computer maker reported fourth-quarter profit fell to 114.8 million rupees ($2.5 million) from 672.3 million rupees a year ago, the company said in a statement to the Bombay Stock Exchange yesterday.

Panacea Biotec Ltd. (PNCB IN) plunged 19.5 percent to 144.8 rupees, the most since Oct. 2008. The World Health Organisation has delisted the company’s diphtheria-pertussis-tetanus-based combination and hepatitis-B vaccines from its list of pre-qualified medicines, the Indian company said in a release to the Bombay Stock Exchange yesterday. Current batches that have already been distributed are safe and will not be recalled.

To contact the reporters on this story: Hemal Savai in Mumbai at at hsavai@bloomberg.net

To contact the editor responsible for this story: Darren Boey at dboey@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.